More Data Than Options for the "No-Option" Refractory Angina Patient in the United States

Affiliations

Free article

Editorial

Robert F Riley et al. Circ Res. 2019.

Free article

. 2019 Jun 7;124(12):1689-1691.

doi: 10.1161/CIRCRESAHA.119.315138. Epub 2019 Jun 6.

¹ From the Christ Hospital Heart and Vascular Center / The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH.

No abstract available

Keywords: Editorial; angioplasty; cell therapy; coronary artery disease; refractory angina; revascularization; stem cell.

Comment in

Response by Riley et al to Letter Regarding Article, "More Data Than Options for the 'No-Option' Refractory Angina Patient in the United States".
Riley RF, Kereiakes DJ, Henry TD. Riley RF, et al. Circ Res. 2019 Oct 11;125(9):e42. doi: 10.1161/CIRCRESAHA.119.315845. Epub 2019 Oct 10. Circ Res. 2019. PMID: 31600126 No abstract available.
Letter by Picichè and Versaci Regarding Article, "More Data Than Options for the 'No-Option' Refractory Angina Patient in the United States".
Picichè M, Versaci F. Picichè M, et al. Circ Res. 2019 Oct 11;125(9):e40-e41. doi: 10.1161/CIRCRESAHA.119.315838. Epub 2019 Oct 10. Circ Res. 2019. PMID: 31600129 No abstract available.

The Impact of Cell Therapy on Cardiovascular Outcomes in Patients With Refractory Angina.
Jones DA, Weeraman D, Colicchia M, Hussain MA, Veerapen D, Andiapen M, Rathod KS, Baumbach A, Mathur A. Jones DA, et al. Circ Res. 2019 Jun 7;124(12):1786-1795. doi: 10.1161/CIRCRESAHA.118.314118. Epub 2019 Mar 29. Circ Res. 2019. PMID: 30922167